159686-96-1 Usage
Uses
Used in Scientific Research:
5-(4-Methyl-1H-imidazol-1-yl)-2-nitrobenzonitrile is used as a research compound for its potential medicinal properties. It is of interest to scientists due to its potential applications in the development of new pharmaceutical agents.
Used in Medicinal Chemistry:
In the field of medicinal chemistry, 5-(4-Methyl-1H-imidazol-1-yl)-2-nitrobenzonitrile is used as a starting material or intermediate in the synthesis of new compounds with potential therapeutic applications. Its unique structure and biological activity make it a valuable candidate for further exploration and development.
Used in Pharmaceutical Development:
5-(4-Methyl-1H-imidazol-1-yl)-2-nitrobenzonitrile is used as a potential anti-cancer agent in the pharmaceutical industry. Its effects on cell proliferation and apoptosis are being studied to determine its potential as a treatment for various types of cancer.
Used in Drug Discovery:
5-(4-Methyl-1H-imidazol-1-yl)-2-nitrobenzonitrile is used in drug discovery processes to identify new lead compounds with potential therapeutic effects. Its unique chemical structure and biological activity make it a promising candidate for the development of novel drugs.
Used in Cancer Research:
In cancer research, 5-(4-Methyl-1H-imidazol-1-yl)-2-nitrobenzonitrile is used to study the mechanisms of action that contribute to its anti-cancer properties. Understanding these mechanisms can help researchers develop more effective treatments for cancer patients.
Check Digit Verification of cas no
The CAS Registry Mumber 159686-96-1 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,5,9,6,8 and 6 respectively; the second part has 2 digits, 9 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 159686-96:
(8*1)+(7*5)+(6*9)+(5*6)+(4*8)+(3*6)+(2*9)+(1*6)=201
201 % 10 = 1
So 159686-96-1 is a valid CAS Registry Number.
159686-96-1Relevant articles and documents
6-1H-IMIDAZO-QUINAZOLINE AND QUINOLINES DERIVATIVES, NEW MAO INHIBITORS AND IMIDAZOLINE RECEPTOR LIGANDS
-
Page/Page column 34, (2010/01/12)
The present invention is directed to 6-(1H-imidazo-1-yl)-2-aryl and 2-heteroaryl quinazoline and quinolines derivatives, compounds of formula (I), their pharmaceutical acceptable salts and solvates and corresponding pharmaceutical compositions, that acts
NITROGEN-CONTAINING FUSED-HETEROCYCLE COMPOUNDS
-
, (2008/06/13)
The present invention relates to a nitrogen-containing heterocyclic compound exhibiting an inhibitory activity against cGMP-PDE. The compound represented by the formula (I) or a pharmacologically acceptable salt thereof: wherein R1 represents a group repr